@article{3078347,
    title = "Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19",
    author = "Tsiambas, E. and Papanikolaou, V. and Chrysovergis, A. and Mastronikolis, N. and Ragos, V. and Kavantzas, N. and Lazaris, A.C. and Kyrodimos, E.",
    journal = "Pathology and Oncology Research",
    year = "2020",
    volume = "26",
    number = "4",
    pages = "2823-2825",
    publisher = "Springer-Verlag",
    issn = "1219-4956",
    doi = "10.1007/s12253-020-00810-6",
    keywords = "angiotensin converting enzyme 2;  furin;  guanine nucleotide binding protein;  hypoxia inducible factor 1alpha;  vasculotropin;  vasculotropin receptor;  angiotensin converting enzyme 2;  biological marker;  dipeptidyl carboxypeptidase, Coronavirinae;  coronavirus disease 2019;  hACE2 gene;  hematologic malignancy;  human;  hypoxia;  Letter;  Middle East respiratory syndrome coronavirus;  mortality rate;  nonhuman;  oxygen supply;  phylogeny;  RNA sequence;  SARS coronavirus;  Severe acute respiratory syndrome coronavirus 2;  single nucleotide polymorphism;  virus cell interaction;  virus entry;  virus genome;  virus pneumonia;  Betacoronavirus;  complication;  Coronavirus infection;  genetics;  hematologic disease;  immunocompromised patient;  pandemic;  pathogenicity;  pathophysiology;  physiology;  virology;  virus pneumonia, Betacoronavirus;  Biomarkers;  Coronavirus Infections;  Hematologic Neoplasms;  Humans;  Immunocompromised Host;  Pandemics;  Peptidyl-Dipeptidase A;  Pneumonia, Viral;  Polymorphism, Single Nucleotide"
}